Mensching Leonore, Beiersdorfer Maya, Schloer Sebastian, Köllmann Sandra, Reinsberg Friederike, Padoan Benedetta, Fittje Pia, Trenkner Timo, Zaayenga Annika, Martrus Gloria, Almahfoud Maher, Stürzel Christina M, Sauter Daniel, Kirchhoff Frank, Schulze Zur Wiesch Julian, Altfeld Marcus, Garcia-Beltran Wilfredo F, Hoelzemer Angelique
Department of Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
Research Department of Virus Immunology, Leibniz Institute of Virology, Hamburg, Germany.
iScience. 2025 Jun 11;28(7):112879. doi: 10.1016/j.isci.2025.112879. eCollection 2025 Jul 18.
Natural killer (NK) cells are innate cytotoxic lymphocytes with antiviral functions explored in "shock and kill" strategies to eliminate the HIV-1 reservoir. For optimal activity against infected targets, NK cells require priming. This study examined how macrophages prime NK cells following HIV-1 infection. We found that HIV-1-infected monocyte-derived macrophages upregulated membrane-bound IL-15Rα, NKG2D ligands, CD48, and IL-18. While crosstalk between NK cells and infected macrophages enhanced proinflammatory cytokine production, it led to only weak priming of NK-cell cytotoxicity. In people living with HIV-1 (PLWH) on antiretroviral therapy, macrophage priming remained intact and polyfunctional, with the strongest response in CD56 KIR+ and/or NKG2A+ NK cells. However, CD56 NK cells -a subset unique to HIV-1 infection- remained dysfunctional. These findings elucidate how HIV-1 alters macrophage-NK cell crosstalk and underscore the need for therapeutic strategies that enhance NK-cell cytotoxicity in efforts toward a functional HIV-1 cure.
自然杀伤(NK)细胞是先天性细胞毒性淋巴细胞,具有抗病毒功能,在“电击杀伤”策略中用于消除HIV-1储存库。为了对受感染靶标发挥最佳活性,NK细胞需要启动。本研究考察了HIV-1感染后巨噬细胞如何启动NK细胞。我们发现,HIV-1感染的单核细胞衍生巨噬细胞上调了膜结合型IL-15Rα、NKG2D配体、CD48和IL-18。虽然NK细胞与受感染巨噬细胞之间的相互作用增强了促炎细胞因子的产生,但它仅导致NK细胞细胞毒性的微弱启动。在接受抗逆转录病毒治疗的HIV-1感染者(PLWH)中,巨噬细胞启动保持完整且具有多功能性,在CD56 KIR+和/或NKG2A+ NK细胞中反应最强。然而,CD56 NK细胞——HIV-1感染特有的一个亚群——仍然功能失调。这些发现阐明了HIV-1如何改变巨噬细胞-NK细胞的相互作用,并强调了在努力实现功能性治愈HIV-1的过程中,需要采取增强NK细胞细胞毒性的治疗策略。